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Abstract.  Cells of the rat pheochromocytoma clone 
PC12 possess receptors for both nerve growth factor 
(NGF) and epidermal growth factor (EGF), thus en- 
abling the study of the interaction of these receptors in 
the regulation of proliferation and differentiation. 
Treatment of the cells with NGF induces a progressive 
and nearly total decrease in the specific binding of 
EGF beginning after 12 h and completed within 4  d. 
Three different measures of receptor show that the de- 
creased binding capacity represents, in fact, a de- 
creased amount of receptor: (a) affinity labeling of 
PC12 cell membranes by cross-linking of receptor- 
bound ~25I-EGF showed a 60-90%  decrease in the 
labeling of 170- and 150-kD receptor bands in cells 
treated with NGF for 1-4 d; (b) EGF-dependent phos- 
phorylation of a src-related synthetic peptide or EGF 
receptor autophosphorylation with membranes from 
NGF-differentiated cells showed a decrease of 80 and 
90%  in the tyrosine kinase activity for the exogenous 
substrate and for receptor autophosphorylation, respec- 
tively; (c) analysis of 35S-labeled glycoproteins isolated 
by wheat germ agglutinin-Sepharose chromatography 
from detergent extracts  of PC12 membranes showed a 
70-90%  decrease in the 170-kD band in NGF-differen- 
tiated cells.  These findings permit the hypothesis that 
long-term heterologous down-regulation of EGF recep- 
tors by NGF in PC12 cells is mediated by an alteration 
in EGF receptor synthesis. It is suggested  that this het- 
erologous down-regulation is part of the mechanism by 
which differentiating cells become insensitive to 
mitogens. 
T 
HE rat pheochromocytoma clone PC12 has been used 
as a model of  neuronal differentiation because the cells 
acquire neuronal  properties  and stop dividing in re- 
sponse to nerve growth factor (NGF) ~ (Greene and Tisch- 
ler, 1976). The differentiation induced by NGF appears to be 
reversible, but, except for this, the changes that occur lead 
to cells with the phenotype of sympathetic neurons (Kimhi, 
1981). The PC12 cells, of course, carry NGF receptors (Her- 
rup and Thoenen, 1979; Landreth and Shooter, 1980) and the 
binding of  NGF to these specific receptors triggers many and 
diverse  arrays of cellular  responses,  including both short- 
term, rapid membranal  changes, and long-term alterations 
in cell properties  associated with changes in transcription 
(Guroff, 1983). Among these responses, NGF-induced dif- 
ferentiation in PC12 involves a transition from a mitotic to 
a nonmitotic state. 
In this regard,  it was of interest to observe that the PCI2 
ceils also have receptors for epidermal growth factor (EGF) 
(Huff and Guroff,  1979; Huff et al.,  1981; Boonstra et al., 
1985). This peptide is a potent mitogen for many of the cells 
I. Abbreviations  used in this paper:  EGF, epidermal growth factor; NGF, 
nerve growth factor. 
with which it interacts, and is a mild mitogen for PC12 (Huff 
et al.,  1981). Since the cells, then, have receptors for both 
a differentiating agent and a mitogen, experiments in this lab- 
oratory have been designed to explore what happens when 
the cells are treated with both agents. 
In previous studies it has been shown (Huff and Guroff, 
1979; Huff  et al., 1981) that treatment of the cells with NGF 
reduces the amount of EGF binding to the cells by 80 % or 
more. Scatchard plots have indicated that the number of EGF 
receptors  decreases,  but that the affinity of the remaining 
receptors  for EGF remains constant.  The data also reveal 
that the decrease in receptor number is gradual, progressing 
over a period of several days. These findings suggest that the 
changes in the EGF receptor are part of  the long-term altera- 
tions  caused by NGF and perhaps  involve transcriptional 
regulation. 
In this study, the long-term alteration in EGF-binding ca- 
pacity  of PC12 is  characterized  further and shown to be 
related to an altered concentration of receptor, thus appear- 
ing to be a novel form of heterologous EGF receptor regula- 
tion. The functional implications of  this phenomena with re- 
spect  to the control  of proliferation  and differentiation in 
PC12 cells are discussed. 
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Materials 
NGF was prepared by the method of  Bocchini and Angeletti (1969) and EGF 
by the method of Savage and Cohen (1972). EGF was also obtained from 
Collaborative Research, Inc. (Lexington, MA). For selected experiments 
the NGF was further purified by reverse-phase HPLC as described by Pe- 
trides and Shooter (1986) using a Spherisorb ODS 2 column (LKB Ultropac, 
3  gm; LKB Instruments, Inc., Gaitbersburg, MD). Two linear gradients 
were applied, 10-35 and 35-80% acetonitrile in 1% trifluoroacetic acid, for 
45 min. Peaks were monitored at 226 run. The peak fraction  s were collected 
and lyophilized, and the NGF content evaluated by the ability of the mate- 
rials to induce neurite formation by PC12 cells and by their ability to com- 
pete for the NGF receptor on PCI2 cells. Using identical chromatographic 
conditions, the EGF  was resolved into ct- and  13-EGF as described by 
Matrisian  et  al.  (1982).  Cytochrome  C,  phenylmethylsulfonyl fluoride 
(PMSF), aprotinin, A23187, choline chloride, and phorbol 12-myristate  13- 
acetate were purchased from Sigma Chemical Co. (St. Louis, MO). Sodium 
vanadate was obtained from Fisher Scientific Co.  (Pittsburgh, PA).  Poly- 
clonal antibodies (Dunn et al.,  1986) and monoclonal 151-IgG antibodies 
(Chandler et al.,  1985) against the rat EGF receptor were a gift of Drs. 
W. A. Dunn and A. L. Hubbard (Department of Cell Biology and Anat- 
omy, The Johns Hopkins University School of Medicine, Baltimore, MD). 
Antisera raised against NGF and EGF were purchased from Collaborative 
Research Inc.  Electrophoresis reagents and  molecular weight standards 
were obtained from Bio-Rad Laboratories (Richmond, CA). All other re- 
agents were of the highest quality available. 
Cell Culture 
PC12 cells were cultured at 37°C as monolayers in 150--cm  2 culture flasks 
in DME (Gibco, Grand Island, NY) supplemented with 7% FBS, 7% horse 
serum, and 100 gg of streptomycin and 100 U of penicillin/mi. The cells 
were split in a  1:4 or 1:6 ratio each week and the medium changed once 
during the week. Human carcinoma A431 cells and rat kidney VB4T cells 
(obtained from Dr. J.  DeLarco, Laboratory of Viral Carcinogenesis, Na- 
tional Institutes of Health) were grown in the same medium. Hybridoma 
cells yielding 151-IgG were grown as previously described (Chandler et al., 
1985). 
Plasma Membrane Preparation and Solubilization 
Cells were harvested in 10 ml of borate buffer (0.05 M borate, 0.15 M NaC1, 
1 mM MgCI2, pH 7.3), and collected by low-speed centrifugation. The cell 
pellet was washed twice with PBS (Ca  2+ and Mg  2+ free) containing 2 mM 
PMSF and 0.1% aprotinin. The cells were disrupted at 4°C by high speed 
polytron homogenization for  10 s  followed by  10 strokes of mechanical 
homogenization. The extent of lysis was monitored by microscopic exami- 
nation. One-half  volume of  60% sucrose in PBS was added and the homage- 
nate was centrifuged at 500 g for 10 min to remove intact cells and nuclei. 
The clarified lysate was layered on 35% sucrose in PBS and centrifuged at 
25,000  g for 1 h. The membranal band on the surface of the sucrose was 
harvested, resuspended in a convenient volume of PBS, and the membranes 
were collected by centrifugation at 100,000 g for 10 min at 4°C. Protein con- 
centration was determined by the lowry method (Lowry et al.,  1951), the 
membrane protein was adjusted to a concentration of I mg/ml, and the sus- 
pension stored at -700C. Membrane solubilization was performed with 1% 
Triton X-100 plus  1%  SDS in 20 mM N-2-hydroxyethyl-N'-2-piperazine- 
ethane sulfonic acid (Hepes), pH 7.4,  containing  10%  glycerol, 0.15 M 
NaCI, 0.2 mM PMSF, 1% aprotinin, and 1 mM EDTA. Insoluble material 
was removed by centrifugation for 20 min at 100,000 g. 
lodination of  Growth Factors  and Binding Assays 
Growth factors were iodinated by the solid phase lactoperoxidase method 
(Tower et al.,  1977) using Enzymobeads (Bio-Rad Laboratories) and iso- 
lated by a microcolumn procedure (Tuszynski et al.,  1980). Specific EGF 
binding  was  measured  according  to  Carpenter  (1985).  Cell-associated, 
specific binding of growth factors was measured by adding labeled factor 
(1-2  x  10  s cpm/mi, 70-150 pg/mi) to monolayer cultures of cells in fresh 
growth medium. The cells were incubated at 37°C for 45 min after which 
the radioactive medium was removed. The monolayers were washed twice 
with cold PBS. 
The location of cell-bound growth factor was determined as previously 
reported (Haigler et al.,  1980). The monolayers were treated at 4°C for 5 
min with acetic acid (0.2  M  in 0.5  M  NaCI),  to  remove cell  surface- 
associated factor.  The remaining internalized  a25I-EGF was  removed by 
solubilizing the cells in 1 N NaOH. 
Nonspecific binding was determined in the presence of 10  -7 M growth 
factor and was estimated as 5 and 25% of total binding for EGF and NGF, 
respectively. All binding experiments were done in triplicate and the data 
are presented as the mean +  the SD.  Binding studies done using plasma 
membrane preparations were performed similarly, at 4°C, except that free- 
and membrane-bound factors were separated by microfuge centrifugation 
for 10 min at 4°C (Beckman Instruments, Inc., Palo Alto, CA). Binding 
buffers used for membranal assays, unless otherwise stated, consisted of ei- 
ther PBS or 50 mM Tris-HCI containing 2 mg/ml of ovalbumin, at pH 7.4. 
~25I-EGF binding to the surface of PCI2 cells after papain proteolysis or 
as a function ofpH was done as described by DiPaola and Maxfield (1984). 
PC12 monolayers were rinsed with PBS, and incubated for 10 min at room 
temperature in PBS containing 1 lag/ml of activated papain. The cells were 
then rinsed free of papain by washing three times with PBS and tested for 
125I-EGF binding. 
Homo-Down-Regulation of  EG  F Receptors and 
Determination of  EGF Degradation 
Plasma membrane EGF receptors were down-regulated by incubation of the 
cells at 37°C with unlabeled EGF (10  4  M) for different periods of time. 
Monolayers were washed to remove the unbound EGF and incubated in 
fresh binding buffer (2 h at 37°C) to allow internalization of the remaining 
EGF-receptor complexes. After two additional washes with binding buffer 
the extent of receptor down-regulation was determined by measuring the 
amount of ~25I-EGF binding. 
Measurement of the cell-mediated degradation of 1251-EGF by  PC12 
cells was done as described by Layer and Shooter (1982);  10% TCA was 
used to precipitate the radioactive material in the incubation medium. 
Receptor AJfinity Labeling 
PC12 membranes (300-500 ~tg protein) or A431 carcinoma or kidney cell 
membranes (50 Ilg) were incubated in PBS containing 0.1% ovalbumin at 
4°C for 60 min with 5 nM ~25I-EGF in the absence of any other ligand or 
in the presence of 5 ~tM unlabeled EGF or 1 IxM 151-1gG. The membranes 
were washed intensively with binding buffer, resuspended in 1 ml of binding 
buffer containing 20 ~tl of 25 mM disuccinimidyl suberate (Pierce Chemical 
Co., Rockford, IL), dissolved in dimethyl suifoxide, and incubated for 10 
min at 4°C. The membranes were washed twice with binding buffer and 
twice with 0.25  M sucrose containing 10 mM Tris and 1 mM EDTA, pH 
7.0, and solubilized by heating for 10 min at 100°C with 100 ~tl of double 
strength electrophoresis sample buffer.  Insoluble material was removed by 
centrifugation at 12,000 g for 10 min and the samples were analyzed by eleco 
trophoresis on SDS polyacrylamide gels. The efficiency of affinity labeling 
of the membranes using this procedure is '~10%. 
7)2rosine Kinase Assays 
Measurement of EGF-dependent tyrosine kinase activity was performed by 
the method of Cohen (1983). PC12 cell membranes (200 ~tg of protein) or 
A431 or kidney cell membranes (20 I~g) were preincubated with EGF (50 
ng/ml) for 15 min at 40°C in a reaction buffer containing 20 mM Hepes- 
NaOH, pH 7.2,  0.5 mM MgCI2,  3 mM MnCI2,  and 50 IxM Na3VO4 in a 
final volume of 50 I.tl. The kinase reactions were initiated by the addition 
of 2 IxCi of y-32p-ATP in 50 I~M unlabeled ATE and continued for 2 min, 
unless otherwise stated, at 4°C. The reactions were stopped by the addition 
of SDS sample buffer and the tubes boiled for 10 min. The samples were 
analyzed by SDS PAGE and autoradiography. Detection of  the phosphotyro- 
sine content of the EGF receptor was done by incubation of the polyacryl- 
amide gels in alkali  as detailed by Cooper et al. (1983) to hydrolyze phos- 
phoserine.  The  radioactivity  contained in  the  EGF  receptor band  was 
estimated by densitometric scanning of the resultant antoradiograms and by 
excision of the appropriate portion of the dried gel and subsequent analysis 
by liquid scintillation spectrometry. When the src-related synthetic peptide 
Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly  (100 IIM)  (Penin- 
sula Laboratories, Inc., Belmont, CA) was used as a substrate, the reaction 
was terminated by application of the sample to PBI pbosphocellulose paper 
(Whatman, Inc., Clifton, NJ). The paper was washed with 5% phosphoric 
acid, then with 20% ethanol. The papers were dried and the radioactivity 
counted in a liquid scintillation counter. 
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Slightly subconfluent PC12 and A431 cells were labeled by incubating the 
cells  for  18  h  in methionine-free DME  medium containing 60  IxCi/ml 
L-[35S]m0thionine (Amersham Corp.,  Arlington Heights,  IL). To prepare 
labeled membranes, the cells were washed three times with cold PBS and 
homogenized and centrifuged as previously  described. 3SS-Labeled mem- 
branes were solubilized by treatment for 20 min at 4°C in RIPA buffer (10 
mM Tris, pH 8.5, containing 0.15 M NaCl, 1 mM EDTA, 1% Triton X-100, 
1% sodium deoxycholate, 0.1% SDS, 1 mM PMSE and 1 mg/ml aprotinin). 
One ml of RIPA buffer was added for each mg of protein.  Insoluble material 
was  removed  by centrifugation at  100,000 g  for  l0 min.  The solubilized 
supernatants were either subjected  to lectin chromatography  (or immuno- 
precipitation) immediately  or stored at -70°C for later analysis.  Immuno- 
precipitation of human EGF receptors  from [35S]methionine-labeled A431 
cells was done with PK-2 antisera by the methods of Kris et al. 0985). The 
immunoprecipitate was  used as  a  reference  for the identification  of the 
EGF-receptor bands on gels. 
Wheat Germ Lectin-Sepharose  Chromatography 
The chromatography  was carried out with slight modifications  of a previ- 
ously described procedure (Cohen et al.,  1982). Wheat germ lectin-Seph- 
arose (100 ~tl of gel packed  into 1 ml Eppendorf pipette tips plugged with 
glass wool) was equilibrated with 10 ml of 20 mM Hepes buffer, pH 7.4, 
containing 0.2%  Triton  X-100,  10%  glycerol,  0.5  mM  EGTA,  0.5  mM 
EDTA, 0.1 mM PMSF, and 50 ~tM Na3VO4. 200-~tl portions of RIPA ex- 
tracts of [35S]methionine-labeled or unlabeled membranes (450 Ixg of pro- 
tein) were applied to the gels; the gels were then washed by centrifugation 
five times with 1 ml portions of equilibration buffer. Then the gels were ei- 
ther eluted with N-acetylglucosamine  (300 raM) in the equilibration buffer 
for desorption of the bound glycoproteins  or dissolved  directly in double 
strength SDS sample buffer and held at 100°C for 10 min. Samples of chro- 
matographed,  unlabeled  membranes  were  analyzed  for  protein  kinase 
activity. 
Figure 1. Time course of the NGF- 
mediated  hetero--down-regula- 
tion of ~25I-EGF binding to PC12 
cells. Cells were grown in control 
medium (o -  -  -  o) or in medi- 
um with 2  x  10  -9 M  NGF, in the 
presence (A -  -  -  A) or absence 
(o---  e)  of  anti-EGF  anti- 
serum  (135  ~tg/ml).  Binding  of 
t~I-EGF (0.2  x  106 cpm/l~ cells) 
was  measured by  incubation for 
45  min at  37°C  at the indicated 
time points, in the presence or ab- 
sence  of excess  unlabeled  EGF 
(10  4  M). The cells were exposed 
to  NGF  (NGE  arrow)  1 d  after 
splitting and fresh NGF was added 
every 48 h. 5 d later, in a separate 
experiment, the cells were washed 
(W,  arrow)  with  fresh  medium 
and  cultured  in  the  absence  of 
NGF  before  the  binding  assay. 
Each binding point represents the 
mean  +  SD of two experiments 
performed in triplicate. The upper 
inset  shows  control  PC12  cells 
(/eft)  and  typical  process  out- 
growth  induced by 2  x  10  -s  M 
NGF after 2 (center) and 4 (right) 
d  of treatment.  The  lower inset 
shows the blocking effect of anti- 
EGF  antiserum  on  the  down- 
regulation  of  EGF  receptors  by 
EGE  PC12 cells were  incubated 
at  37°C  for  the  indicated  time 
periods  with  EGF  (0.2  nM)  in 
DME.  Monolayers were  washed 
to remove the unbound factor and 
incubated  in  fresh  DME  (1  ml) 
for 2 h at 37°C to internalize the re- 
maining EGF-receptor complex- 
es.  After  two  additional  washes 
with medium, the extent of recep- 
tor  down-regulation  was  deter- 
mined by measuring the amount 
of specific  125I-EGF binding un- 
der conditions detailed  in Mate- 
rials and Methods. 
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Gel electrophoresis was performed for 4 h at 100 V according to Laemmli 
(1970) using a 3 % stacking gel and a 7.5 % separating gel. After electropho- 
resis the gel was stained with 0.05% Coomassie Blue in 45% methanol, 9% 
acetic acid,  and destained in  10%  acetic acid,  10%  n-propanol.  Gels of 
[35S]methionine-labeled membranes were treated with enhancer (Enlight- 
ening; New England Nuclear, Boston, MA) for 30 min. The gels were dried 
under vacuum and exposed to Kodak XAR-5 film at -70°C using an inten- 
sifying screen (DuPont Lighting Plus; DuPont Co., Diagnostic and Bio- 
Research Systems, Wilmington, DE).  Autoradiograms were scanned with 
a laser densitometer (Zeineh Soft Laser Densitometer; LKB Instruments, 
Inc., Uppsala, Sweden) and the bands corresponding to the EGF receptor 
were cut out, treated with 500 Ixi of NCS tissue solubilizer, and then counted 
in 10 ml of scintillant (Aquasol; Amersham Corp., Arlington Heights, IL). 
Alkaline treatment of the gels was performed by shaking reswollen gels in 
1 N NaOH for 2 h at 55°C. The gels were washed several times with 15% 
acetic acid, twice with destaining solution, dried, and subjected to an addi- 
tional autoradiography. 
Estimation of  Membrane Potential and Depolarization 
The estimation of PC12 membrane potential was performed according to an 
established procedure (Milligan and Strange,  1984).  Uptake of ~4C-tetra- 
phenylphosphonium bromide  into  control  and  NGF-differentiated  PC12 
cells suspended in choline buffer (120 mM choline chloride, 5 mM KCI, 
2 mM CaCI2,  1 mM MgC12, 0.2 mM Tris-HCi, 10 mM glucose, pH 7.4) 
was initiated by the addition of 0.1  laCi of r4C-tetraphenylphosphonium 
bromide (60 nM) and the incubation continued for 45 rain at 37"C.  The 
monolayers were washed with choline buffer containing 0.1% BSA and cell- 
associated radioactivity  was  estimated after  the  addition  of scintillant. 
Depolarization of the cells was done by replacement of choline with the in- 
dicated concentration of potassium. 
Results 
Time Course and Specificity of  Reduction 
in EGF-binding Capacity 
The capacity of NGF-differentiated PCL2 cells to interact 
with  ~25I-EGF was  examined relative to the NGF-induced 
changes in morphology. The results from such an experiment 
are  shown  in  Fig.  1.  Treatment  of the  cells  with  NGF 
significantly reduced the binding capacity of the cells for 
EGF after a latency period of 12-24 h. After 5-7 d of NGF 
treatment a near-total disappearance of EGF-binding capac- 
ity  was  observed.  Withdrawal  of NGF  from the  culture 
medium  was  accompanied by  a  gradual  reappearance of 
EGF-binding capacity (Fig.  1). The initial decline in EGF- 
binding capacity correlates in a general way with the appear- 
ance of the NGF-induced morphological changes, e.g., cell 
hypertrophy, process formation (Fig. 1, top), properties typi- 
cal of terminally differentiated neurons (Guroff, 1983). The 
effect of NGF on the EGF-binding capacity of the differen- 
tiated cells is concentration dependent and maximal around 
2  ×  10  -9 M  (Fig.  1). 
The effect of NGF treatment on EGF binding is unaffected 
by the presence of an excess of anti-EGF antibodies in the 
culture medium during the treatment (Fig. 1) or by a preincu- 
bation of the NGF preparation with these antibodies (data 
not shown). The concentration of anti-EGF antibodies used 
in the former experiment was sufficient to block the homo- 
down-regulation of EGF receptors by EGF (Fig. 1). Further- 
more, the reduction in EGF binding caused by treatment 
with the standard preparation of NGF was also caused (Table 
I) by treatment with an HPLC-purified peak of NGF eluted 
with 33-35 % acetonitrile (Petrides and Shooter, 1986) with 
a retention time of 32.2 min. The reduction in EGF-binding 
Table L Effect of  Antibodies on NGF-induced 
Hetero-Down-Regulation of  EGF  Receptors in PC12 Cells 
Neurite  ~2~I-EGF specific  binding 
Antiserum  formation  (percent of control) 
lt g  /ml 
-  +++  34.9 
Anti-NGF antiserum (200)  +  92.5 
Anti-EGF antiserum (135)  +++  36.0 
PCI2 cells were treated for 3 d with 2  ×  10  -8 M HPLC-purified NGF in the 
presence or absence of various antisera. Neurite formation and ~2SI-EGF bind- 
ing to the washed cells was measured as described in Materials and Methods. 
The data on EGF binding represents the mean of triplicates  and is presented 
as a percentage of the specific  t251-EGF binding to control cells. 
capacity  produced  by  treatment  with  the  HPLC-purified 
NGF could be blocked completely by anti-NGF antiserum, 
but not by anti-EGF antiserum (Table I). These results, as 
well as the absence of any competitive inhibition by the NGF 
preparation (up to 10  -6 M) of EGF binding to PC12 mem- 
branes  (data  not  shown),  clearly  show  that  the  down- 
regulation of EGF receptors by treatment with NGF is not 
due to contamination of the NGF preparation with EGE 
This EGF receptor modulation is quite specific for NGF 
(Table II).  Neither cytochrome C  nor insulin affected the 
EGF-binding capacity of PCI2 cells. Furthermore, fibroblast 
growth factor, which also causes the formation of cell pro- 
cesses in PC12 cells (Togari et al.,  1985),  did not induce a 
reduction in the EGF-binding capacity. This NGF-induced 
reduction in EGF binding has quite different characteristics 
than does the NGF-induced down-regulation of NGF recep- 
tors (Fig. 2). At a high NGF concentration, a rapid down- 
regulation of NGF receptors was seen; this was followed by 
a gradual recovery process in which "~50% of control bind- 
ing levels were observed after 3  d.  A  second addition of 
NGF caused another rapid down-regulation of the receptors. 
Therefore, under comparable conditions the  reduction in 
EGF-binding capacity is much slower than the reduction in 
NGF binding. This is consistent with previous experiments 
showing that NGF receptors and EGF receptors are separate 
entities in PC12 cells (Huff et al.,  1981) as they are in other 
cells. 
NGF-induced Reduction in EGF-binding Capacity 
Is Seen with Isolated Membranes 
A progressive reduction in EGF-binding capacity was seen 
when binding was measured with plasma membranes iso- 
Table II. Specificity of  NGF-induced Hereto-Down- 
Regulation of  EGF Receptors in PC12 Cells 
Compound  Neurite  ~25I-EGF 
tested  Concentration  formation  specific  binding 
M  fmol/#g protein 
None  -  -  5.8  +  0.3 
Cytochrome C  10  -6  -  5.6  +  0.2 
Insulin  10  -6  -  6.5  _+  0.5 
Fibroblast growth factor  10  -7  +  6.0  +  0.3 
NGF  10  -9  ++@  3.8  +  0.2 
125  Ceils were treated for 4 d. Binding of  I-EGF to the washed cells was mea- 
sured as described in  Materials and Methods.  Each number represents the 
mean +  SD of four determinations. 
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Figure 2. Time course of NGF-receptor homo-down-regulation in 
PC12 cells.  Cells  were grown under conditions identical  to those 
described  in  Fig.  1.  Specific  binding  of  t25I-NGF (0.3  x  106 
cpm/l@ cells)  was measured by incubation for 30 min at 37°C at 
the indicated  time points.  The cells  were exposed to NGF (NGF, 
arrow) 1 d after splitting  at a high (2  x  10  -8 M,  •  -  -  -  e) or a 
low (2  x  10  -l° M,  •  -  -  -  •) concentration.  After 2 d of NGF 
treatment, half of the cultures  received  a new dose of 2  x  10  -8 M 
NGF (NGF, arrow, dotted line), before the binding  assay. 
lated from NGF-differentiated PC12 cells (Fig.  3 A). Equi- 
librium binding studies were carried out with isolated mem- 
branes from control and from NGF-differentiated cells. The 
binding of EGF to both populations of membranes was con- 
centration dependent and saturable,  but significantly differ- 
ent.  Since  decreased  binding  relative  to membranes  from 
control cells was observed at all concentrations of 125I-EGF 
examined (Fig. 3 B), these data suggest that the reduction of 
EGF-binding capacity in NGF-differentiated cells is due pri- 
marily to a change in the number of receptor sites; this data 
supports that previously obtained with intact PC12 cells by 
Scatchard analysis (Huff et al.,  1981). 
Characterization of the NGF-induced Decrease in 
EGF-binding Capacity of  Differentiated PC12 Cells 
by Cross-linking 
To obtain  further  proof that a  reduction  in the  number of 
EGF receptors is the cause of the reduced binding capacity 
A  8L. 
# 
0  ~  ~ 
Days of NGF Treatment  EGF(  10  9M) 
Figure 3. Characteristics  of NGF-induced loss of EGF binding to 
isolated PC12 membranes. (A) Time course and (B) concentration 
dependence of EGF binding to membranes isolated  from control 
and NGF-diffcrentiated  PC12 cells. In A cells were grown in control 
medium or in NGF-containing (2  x  10  -9 M) medium. Cell mem- 
branes were isolated by the sucrose layer method and analyzed by 
the membrane-binding assay described in Materials  and Methods. 
In B indicated  concentrations of unlabeled  EGF were mixed with 
125I-EGF (0.05 ng).  Each point represents  the mean of triplicate 
determinations. 
Figure 4.  Cross-linking of 125I-EGF to its receptor in control and 
in NGF-treated  PC12 cells.  (Lej~) Time course of nerve growth 
factor-mediated  decrease; (right), specificity. Membranes isolated 
from cells grown in the absence or presence of NGF as described 
in Fig.  1 were incubated  for 60 min on ice with 5 nM ~25I-EGF  in 
the absence of  any other ligand or in the presence of 5 ~tm unlabeled 
EGF (+EGF). Cross-linking with 0.5 ~tm disuccinimidyl suberate 
was performed as described under Materials and Methods.  Samples 
of detergent-solubilized  membranes were subjected to 7.5 % PAGE. 
The autoradiograms of the fixed, dried gels are presented.  The mo- 
lecular weights of EGF-cross-linked  receptors  are indicated on the 
left.  A431,  carcinoma cell  membranes;  PC12,  PCI2 cell  mem- 
branes;  C, control; lanes  1, 2, 3, and 4, NGF-differentiated  cells 
treated  for 1, 2, 3, and 4 d, respectively. 
of PCI2 cells differentiated with NGF, EGF was cross-linked 
to its receptors with succinimidyl suberate. Membranes from 
control and from differentiated cells were isolated, carefully 
normalized  for protein,  cross-linked  with bound  tESI-EGE 
and analyzed by electrophoresis and autoradiography (Fig. 
4).  Cross-linking  of I25I-EGF to membranes  from control 
PC12 cells resulted in the labeling of a major component of 
170,000 D and a minor component of 150,000 D; the pattern 
was identical to that obtained with membranes  from A431 
cells (Fig. 4,  -EGE  A431 and PC12, lane C). In A431 cells 
it has been shown that a proteolytic product of the 170,000-D 
EGF receptor is a  species of 150,000 D  (Casel and Glaser, 
1982).  Complete  disappearance  of  the  labeling  of  these 
bands in the presence of excess unlabeled EGF demonstrated 
that they indeed represent L~I-EGF/EGF receptor complexes 
(Fig. 4,  +EGE A431 and PC12, lane C). Formation of the 
170,000-  and  150,000-D  ~2SI-EGF/EGF receptor complexes 
was also inhibited by ,,o80 % in the presence of the monoclo- 
nal antibody 151-IgG that was recently observed to be a com- 
petitive  inhibitor  of EGF  binding  to  PCI2  cells  (data  not 
shown) (Chandler et al.,  1985); this data supports the spec- 
ificity of the cross-linking to the EGF receptor. Analysis of 
the cross-linked EGF  receptor bands  in PC12 cells treated 
with  NGF  for  1 d  indicates  60 and  53%  reduction in the 
labeling  intensity  of the  170,000-  and  150,000-D  species, 
respectively (Fig. 4, -EGE  PC12, lane 1 ). After 2 d of NGF 
treatment  the  intensity  of labeling  of both  EGF  receptor 
bands was decreased >90%  (Fig. 4,  -EGE  PCI2, lane 2), 
and after 4 d of NGF treatment the receptor bands represent 
only a  few percent of the values obtained with control cells 
(Fig. 4,  -EGE  PC12, lane 4).  This decrease in labeling is 
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membranes from control PC12 cells. Membranes (250 ~tg protein) 
were  incubated  for 2  min with  "f-32P-ATP under  conditions  de- 
tailed in Materials and Methods. The numbers to the left indicate 
~4C-molecular weight  calibration  markers.  Lane  1,  kidney  cell 
membranes; lane 2, PC12 membranes in regular tyrosine kinase as- 
say buffer; lane 3, Mn  2+ absent; lane 4, sodium vanadate absent; 
lane 5,  EGF, 5  ×  10  -9 M;  lane  6, EGF, 0.5  ×  10  -9 M;  lane  7, 
EGF, 0.1  ×  10-9 M; lane 8, EGF absent. 
consistent with a lower number of EGF receptors in NGF- 
differentiated PC12  cells. 
Characterization of  EG  F-stimulated l~rosine 
Kinase Activity in Control PC12 Cell Membranes 
Another  reflection  of an  NGF-induced  decrease  in  EGF 
receptor  number would  be  a  decrease  in  EGF-stimulated 
tyrosine kinase activity in differentiated PCI2 cells. Because 
tyrosine kinase activity is very low in  PCI2 cells and the 
alkaline  lysis  method  commonly  used  in  EGF  receptor 
studies is damaging to PC12 cell receptor activities (unpub- 
lished data), we have searched for conditions that are optimal 
for the measurement of tyrosine kinase activity and, at the 
same time, under which tyrosyl phosphatases are inhibited. 
The EGF receptor kinase activity has been shown to be en- 
hanced (relative to serine or threonine kinases) when reac- 
tions are performed in the presence of manganese rather than 
magnesium (Carpenter et al.,  1979) and in the presence of 
vanadate, a protein phosphatase inhibitor (Brautigan et al., 
1981; Swamp et al., 1982). As shown in Fig. 5, EGF receptor 
autophosphorylation  in  control  PC12  cell  membranes  is 
stimulated severalfold by EGF when the phosphorylation as- 
say media contained manganese and vanadate (Fig.  5,  lane 
2); in the absence of manganese (lane 3), vanadate (lane 4), 
or EGF (lane 8) the autophosphorylation is much lower. The 
ability of EGF to stimulate EGF receptor autophosphoryla- 
tion was found to be dose dependent (Fig. 5, lanes 5-7) and 
almost maximal at 5  x  10  -9 M  EGF (Fig.  5,  lane 5).  The 
specificity  of the  EGF  stimulation  of EGF  receptor  au- 
tophosphorylation  is  quite  strict;  no  stimulation  was  ob- 
served  upon  addition  of FGF,  NGF,  or  insulin  (data  not 
shown). The rate of autophosphorylation of the EGF recep- 
tor increased linearly with increasing concentration of mem- 
branes up to 2 mg/ml after which no further increase was ob- 
served in the 2-min assay (data not shown). The time course 
of EGF-stimulated receptor autophosphorylation in vitro in 
control  PCI2  cell  membranes is  linear  for  ~5  min  when 
measured at a low temperature and a high ATP concentration 
(data not shown). The basal autophosphorylation activity of 
the EGF receptor continued to increase during the incuba- 
tion  and  after  10  min  was  very  close  to  EGF-stimulated 
values. Results from six different batches of control PCI2 cell 
membranes indicate a basal EGF-receptor autophosphoryla- 
tion activity of 20 -1- 7 % of the total receptor tyrosine kinase 
activity and a five- to 10-fold stimulation by EGF compared 
with basal activity when measured in the 2 min assay. The 
effect of EGF on the tyrosine kinase activity of the receptor 
was seen even more clearly after the gels were exposed to 
alkali (Fig. 6), which preferentially hydrolyzes phosphoser- 
ine.  Comparison of identical gels before (Fig. 6 A, lane 2) 
and after (Fig. 6 B, and 2) alkaline treatment found that 75 % 
of the 32p content of the receptor band remained. These ex- 
periments clearly indicate that most of the phosphorylation 
in the 170,000-D EGF receptor band is on tyrosine residues. 
In the  phosphorylation experiments there  is  always EGF- 
dependent phosphorylation of some additional  membranal 
tyrosine-containing  proteins  of "~30,000-45,000  D;  these 
resemble the well-documented EGF-receptor "substrates" in 
A431 cells (Fava and Cohen, 1984). It is important to empha- 
size the absence of any detectable effect of NGF on the phos- 
phorylation of membranal proteins or the synthetic peptide 
(data not shown), thus distinguishing the NGF receptor from 
the EGF receptor and from the other polypeptide growth fac- 
tor receptor kinases.  Since EGF-stimulated receptor auto- 
phosphorylation  might  have  different  properties  than  the 
phosphorylation of physiological or exogeneous substrates 
(Hunter and Cooper,  1985),  the phosphorylation of a src- 
related synthetic peptide by PC12  cell membranes was also 
studied;  such peptides are commonly used as substrates for 
EGF-stimulated tyrosine protein kinase phosphorylation by 
cell membranes (Pike et al., 1982). EGF stimulates the phos- 
Figure 6.  Tyrosine-specific autophosphorylation 
of EGF receptor from PC12 cells. EGF-stimulated 
phosphorylation  of (1)  kidney  cell,  (2)  control 
PC12 cells, and (3 and 4) NGF-treated cell mem- 
branes  analyzed  (A) before and (B and  C) after 
alkali treatment of the polyacrylamide gels. Phos- 
phorylation  conditions and alkali treatment were 
as  described  in  Materials  and  Methods.  Mem- 
brane protein: lane 1, 60 ~g; lane 2, 225 l.tg; lane 
3, 225 p.g; lane 4, 450 ~tg; Autoradiogram expo- 
sure: A, 4 h; B, 12 h; C (the same gel as B), 48 h. 
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by PC12 and Kidney Cell Membranes 
Tyrosine  kinase specific activity 
Autophos-  Peptide phos- 
Preparation  phorylation  phorylation 
(cme/min/mg protein)  (pmol/min/mg protein) 
PCI2,  control cells  0.32  +  0.07  9.0  _  1.5 
PCI2,  NGF-treated cells  0.04  +  0.01  2.0  +  0.7 
VB4T kidney cells  12.00  +  0.14  289  +  14 
PCI2 cell membranes (225 txg protein) or VIMT cell membranes (30 txg pro- 
tein) were incubated for 2 min at 24°C in a final volume of 50 p.l with 50 p.m 
ATP containing  2 IxCi 7-32P-ATP, and the assay buffer as detailed in Mate- 
rials and Methods. For autophosphorylation  measurements the reactions were 
terminated by the addition of double strength SDS-sample buffer and subjected 
to SDS electrophoresis  and autoradiography.  The  EGF receptor  (170,000-D 
band) autophosphorylation was calculated from the peak area of the densitome- 
ter tracing of the autoradiograms.  Phosphorylation of the tyrosine-containing 
peptide (100 ltm) was allowed to proceed for 10 min at 0°C and terminated 
by  applying  40-1xl portions  to  filter paper  (Whatman,  Inc.) as described  in 
Materials  and  Methods.  Phosphorylation  experiments  were  assayed  in  the 
presence  (total activity) and absence (basal activity) of EGF (50 ng/ml) that 
was preincubated with the membranes for 5 min at 4°C. The basal activities 
for peptide phosphorylation  were:  control cells,  3.1;  NGF-treated cells,  1.3; 
VIMT cells,  136. The values presented (mean _+ SD of triplicate experiments) 
represent the difference between total and basal activities. 
phorylation of the src-peptide by membranes from control 
PC12 cells in a 15-min incubation at 4°C about fourfold. The 
specific activity of this phosphorylation by PC12 cell mem- 
branes is 35 times less than the activity of VIMT kidney cell 
membranes (Table III). 
Characterization  of the NGF-induced 
Decrease of  EGF-stimulated I~rosine Kinase Activity 
of Differentiated PC12 Cells 
As seen in a typical experiment (Fig. 6 A), membranes from 
cells treated for 3-4 d with NGF show •60%  decrease (Fig. 
6  A,  lane  3)  in  the  autophosphorylation intensity of the 
170,000-D band, when compared with membranes from con- 
trol cells (Fig. 6 A, lane 2). This is made even more clear 
by increasing the concentration of the membranes from the 
treated cells in the phosphorylation assay (Fig. 6 A, lane 4). 
After alkaline treatment of the gel (Fig. 6 B), the inhibitory 
effect of NGF treatment on EGF receptor autophosphoryla- 
tion is even more evident; the levels in treated cells are no 
more than 20%  of the levels in membranes  from control 
cells. This effect is seen even upon overexposure of the gels 
(Fig. 6 C). Quantitative analyses of the 170,000-D receptor 
bands  from four different batches of membranes of PCl2 
m 
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Figure 7. Rate of internaliza- 
tion  of  ~2SI-EGF in  control 
and  NGF-treated  cells. (e) 
Control; (o) NGF-treated (50 
ng/ml, 4 d). Internalized fac- 
tor was measured by the acetic 
acid wash method described 
in Materials and Methods. 
Table IV. Cellular Processing of I251-EGF  by Control 
and by NGF-treated PC12 Cells 
NGF- 
Control  treated 
Assay  cells  cells 
Disappearance of cell-associated radioactivity 
(%  of initial  binding) 
Appearance of TCA precipitable radioactivity 
(%)  in medium 
3h  9h  3h  9h 
58  20  55  25 
38  74  30  70 
PCI2 cells were incubated for 4 d in the presence or absence of NGF (2  x 
l0  -9 M).  The medium was removed by aspiration  and the monolayers  were 
exposed to ~2SI-EGF (2  x  l06 cpm) in 1 ml of binding medium for 60 min at 
37°C.  The unbound factor was removed by aspiration and washing with fresh 
medium. Fresh binding buffer (4 ml, 7°C) was added to the monolayers and 
degradation of the receptor-bound EGF was determined by measuring the dis- 
appearance of radioactivity from the cells and the appearance of radioactivity 
in the TCA  (10%,  1 ml) precipitates. 
cells treated for 4 d with NGF and expressing long neurite 
processes showed that they incorporated an average of 10 + 
6 % as much 32p as did control cell membranes. In another 
experiment, EGF receptor levels in membranes from control 
and from NGF-differentiated PC12 cells were measured and 
compared by  assaying  both  receptor autophosphorylation 
and src-peptide phosphorylation (Table III). NGF-differen- 
tiated cell membranes showed a decrease of 87 and 78 % in 
the tyrosine kinase activity for receptor autophosphorylation 
and exogenous substrate, respectively. 
Possible Mechanisms Involved in the Decrease in 
EGF  Receptor during NGF-induced Differentiation 
of  PC12 Cells 
A possible mechanism by which NGF might decrease EGF 
receptor number is by an activation of cell-mediated receptor 
internalization. Fig. 7 and Table IV present the results of ex- 
periments evaluating the possible difference in the process- 
ing of ~25I-EGF in control and differentiated cells. The cells. 
were pulsed with  125I-EGF for short periods of time,  sur- 
face-bound factor removed by a rapid acetic acid wash, and 
internalized radioactive epidermal growth factor measured 
(Fig. 7). In addition, internalization and degradation of the 
bound 12SI-EGF was followed by monitoring the overall dis- 
appearance of cell-associated radioactivity and the appear- 
ance of TCA-precipitable degradation products in the medi- 
um (Table IV). The results do not reveal any major difference 
between control and NGF-treated cells. After 2 h of incuba- 
tion a parallel process of degradation occurs in both popula- 
tions (data not shown), resulting after 3 h in 30-40%, and 
after 9 h in 70% precipitable radioactive degradation prod- 
ucts in the medium (Table IV). These studies indicate that 
the internalization and degradation of the EGF receptor is 
similar in control and in NGF-treated cells. 
Studies by others have shown that some lectins (Vale and 
Shooter, 1983), a tumor promoter (Boonstra et al., 1985), or 
certain antibodies (Chandler et al.,  1985) can alter the bind- 
ing properties of EGF receptors in PC12 cells. We have used 
these agents to probe the binding properties of EGF recep- 
tors in control and differentiated cells (Table V). Treatment 
of the cells at 37°C for 20 min gave the expected inhibitory 
effect without any major difference between EGF receptors 
in the two cell populations. 
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to Control and NGF-treated PC12 Cells 
Specific 1251-EGF  binding 
Compound  Concentration  Control cells  NGF-treated cells 
None 
Polyclonal anti-EGF receptor from rat liver 
151 monoclonal IgG anti-PC12  membranes 
Wheat germ agglutinin 
Phorbol  12 myristate  13-acetate 
A23187 
fraol/lO 6 cells  flnol/lO 6 cells 
--  599 +  54  313  +  25 
1:100 dilution of serum  14 +  2  8 +  3 
1:1000 dilution of original  8 +  1  6  +  1 
25 Ixg/ml  138 +  23  120 +  17 
8  x  10  -7 M  388 +  25  227  +  12 
10  -5 M  264  +  19  131  +  13 
Cells were preincubated for 20 min in choline buffer to which the indicated concentrations  of the various compounds  were added. Aliquots of ~2SI-EGF  (0.2 x 
106 cpm/ml) were then added and incubation was continued for 45min at 37°C. Values represent average + SD of triplicate wells. 
Since pH-dependent conformational changes in EGF re- 
ceptors may be important for changes in their affinity or their 
susceptibility to hydrolysis and cellular processing (DiPaola 
and Maxfield,  1984), we have compared the pH dependence 
of EGF binding and its  sensitivity to papain hydrolysis in 
control and differentiated cells (Fig. 8). In both populations 
of cells, a similar pH dependence profile of EGF binding was 
measured with an optimum of ~pH 8.0 (Fig. 8 A). In both 
populations of cells the EGF receptors became resistant to 
papain proteolysis when the pH was lowered from 7.3 to 5.5 
(Fig. 8 B), consistent with the hypothesis that the receptors 
become less exposed to the external media at low pH (DiPaola 
and Maxfield,  1984).  These observations suggest that EGF 
receptors from control and from NGF-treated cells undergo 
overtly similar pH-mediated changes in conformation. 
PCI2 cells differentiated with NGF exhibit resting mem- 
brane potentials of -50 to  -65 mV (O'Lague and Huttner, 
1980),  the  appearance  of voltage-dependent  Na  +  and  K + 
channels  (Arner and StaUcup,  1981),  and Na  ÷,  K+-ATPase 
(Boonstra et al.,  1983), all essentials for their electrical ex- 
citability. Because the degree of transmembrane potential in 
differentiated cells may be a significant factor in determining 
EGF-receptor properties, we have explored the effect of cell 
depolarization  on  t25I-EGF  binding  to  both  control  and 
differentiated cells (Table VI). The results indicate that with 
both populations  of PC12  cells,  125I-EGF binding  is  inde- 
pendent of the transmembrane potential;  this potential was 
significantly affected during the K + depolarization as shown 
by the reduction in the uptake of the lipophilic permeant cat- 
ion,  ~*C-tetraphenylphosphonium bromide (Table VI). 
These experiments, together with the 12-24-h lag time re- 
quired to detect the beginning of the NGF-induced decrease 
in EGF-binding capacity, distinguish the mechanism of NGF 
action  from previously  documented  rapid  effects  of other 
growth factors on EGF receptor affinity reported  in other 
cells (Rozengurt et al.,  1982; Bowen-Pope et al.,  1983). 
Since the NGF-induced decrease in EGF-binding capacity 
in differentiated PC12 cells could be related to an increased 
rate of EGF receptor homodown regulation,  we compared 
the  time  course of EGF-induced homodown regulation  in 
both populations of cells. In the presence of 10 nM EGE the 
binding capacity of both control and differentiated cells was 
reduced to 50%  of its original levels in ~30 min (data not 
shown).  These  results  indicate  that the mechanism of the 
NGF-induced  decrease  in  EGF-binding  capacity  in  PCI2 
cells is not related to the homodown regulation process. 
NGF-induced Reduction in [35S]methionine Labeling 
of  a 170-kD Glycoprotein Band in the Membranes 
of Differentiated PC12 Cells 
The biosynthesis of the EGF receptor was studied by labeling 
control and NGF-differentiated PCL2 cells with [35S]methi- 
onine for 18 h (Mayes and Waterfield,  1984).  For compara- 
tive purposes A431 cells were labeled under identical condi- 
tions. Since a series of monoclonal and polyclonal antibodies 
directed against the human or rat liver EGF receptor were 
found ineffective in the immunoprecipitation of PCI2 EGF 
receptors,  the radioactive cell membranes were solubilized 
with  detergent  and  the  EGF  receptors  enriched  by wheat 
germ agglutinin-Sepharose chromatography, a method pre- 
viously used for the purification of mouse liver EGF recep- 
tors  (Cohen  et  al.,  1982).  Total  radioactive  glycoproteins 
bound to the gel were subjected to gel electrophoresis and 
analyzed  by  autoradiography.  The  predominantly  labeled 
proteins bound to wheat germ agglutinin gels have apparent 
molecular masses of 200,000,  100,000,  95,000,  85,000,  and 
60,000 D (Fig. 9, lanes b and c). The doublet at 170,000 and 
150,000 D was assumed to represent the EGF receptor on the 
basis of (a) the electrophoretic mobility of [35S]methionine 
EGF receptors  immunoprecipitated  from A431  cells  (data 
not shown) and (b) phosphorylation data indicating a single 
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Figure 8. pH characteristics  of 
EGF receptors  in control and 
NGF-treated  PC12 cells.  (A) 
pH  profile  and  (B)  papain 
sensitivity  under different pH 
conditions.  Cells  were trans- 
ferred  to  choline  buffer and 
the media brought to different 
pHs with 3-N-morpholinopro- 
panesulfonic  acid/Hepes buf- 
fers. Binding of t25I-EGF (0.2 
x  106  cpm/ml)  to  cultures 
was carried out for 30 min at 37°C as described in Materials  and 
Methods.  Proteolysis  with  papain (1  lag/ml) was carried out for 
10 rain at room temperature  at an extracellular  pH of 7.3 or 5.5. 
The cells  were then tested  for 125I-EGF binding at  pH 7.3. (A) 
pH profile of binding to control (e -  -  -  e) and to NGF-treated 
(o -  -  -  o) cells. (B) Specific binding to control cells is shown by 
shadowed  hystogram.  Left three columns represent  control cells 
and right three columns represent  NGF-treated  cells. The data are 
the mean + SD of six binding measurements under each condition. 
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in Control and NGF-treated PC12 Cells 
Specific '2~I-EGF binding  [~4C]TPP uptake 
Media  Control cells  NGF-treated  cells  Control  cells  NGF-treated  cells 
Choline buffer 
K ÷ (100 raM)  in choline buffer 
fmol/ltg protein  fmol/#g protein  fraol/Izg protein  fmol/#g protein 
1.9  +  0.1  0.5  +  0.1  5.0  +  0.5  7.2  +  0.3 
2.1  +  0.1  0.5  +  0.1  1.3  +  1.5  3.2  +  0.2 
Binding experiments  with cell cultures were performed  in choline buffer or choline buffer in which choline was replaced by potassium as detailed in Materials 
and  Methods.  Membrane  potential  of the  cell  cultures  was measured  using the  uptake  of [~4C]TPP for 60  min at  37°C  under  normal  (choline  buffer) and 
depolarizing  (K+/choline buffer) conditions as detailed under Materials and Methods.  Uptake values were corrected  for radioactivity trapped in the extracellular 
space.  Values represent  mean  +  SD of triplicate wells. 
major autophosphorylated 170,000-D band adsorbed to the 
wheat germ agglutinin-gels and co-migrating under the same 
electrophoretic  conditions  with  the  35S-labeled  170,000-D 
band (Fig. 9, lane d). Similar patterns were seen when N-ace- 
tylglucosamine (300 gM) was used as an elution buffer (data 
not  shown).  When  the  levels  of  pSS]methionine-labeled 
EGF receptors in control and NGF-differentiated cell mem- 
branes were compared (Fig. 9, lanes b and c), 90 and 50% 
decreases in the level of  the 170,000- and the 150,000-D EGF- 
receptor bands, respectively, were detected. An almost com- 
plete disappearance of both was seen when the carbohydrate 
eluant was analyzed (data not shown). Examination of  the ra- 
tio  [35S]methionine-labeled 170,000- and  150,000-bands  to 
the 200,000-band (the level of which was found unaffected by 
the NGF-induced differentiation) in six different batches of 
control  and  NGF-differentiated cell  membranes  indicates 
Figure  9.  Analysis  of  [35S]- 
methionine incorporation and 
autophosphorylation  of  the 
170,000-D glycoprotein band 
isolated by lectin chromatog- 
raphy from control and NGF- 
treated  PCI2  cells.  [35S]Me- 
thionine  incorporation  into 
the  EGF receptor  in control 
and  NGF-treated  PCI2  cells 
was analyzed by wheat germ 
agglutinin-Sepharose chroma- 
tography.  PC12 cells  were 
labeled  with  [35S]methionine 
for 18 h as described in Mate- 
rials and Methods. The cell monolayers were washed with DME 
containing unlabeled methionine (600 Ixg/ml); labeled cell mem- 
branes were prepared by the sucrose layer method, solubilized with 
RIPA buffer (10 mM Tris, pH 8.5, containing 0.15 M NaCI, 1 mM 
EDlrA,  1%  Triton X-100, 1%  sodium deoxycholate, 0.1% SDS, 
1 mM PMSF, and 1 mg/ml apmtinin) and purified by lectin chro- 
matography as described in Materials and Methods. Under similar 
conditions glycopmteins from unlabeled cell membranes (10 mg of 
protein) were isolated and samples equivalent to 0.5 mg of mem- 
brane protein bound to wheat germ agglutination-Sepharose were 
submitted to EGF-stimulated autophosphorylation with "y-32P-ATP 
for 5 min at 4°C. Phosphorylation conditions and alkali treatment 
were as described in Materials and Methods. (a) [uC] molecular 
weight markers; (b and c) autoradiogram of polyacrylamide gel of 
[35S]-methionine-labeled glycoproteins  from  membranes  of (b) 
control  and  (c)  NGF-treated cells;  (d and  e)  autoradiogram of 
alkali-treated polyacrylamide gel of phosphorylated glycoproteins 
from membranes of (d) control and (e) NGF-treated cells. 
70-90  and  30-50%  decrease in  the  170,000 and  150,000 
receptor species, respectively. Since additional nonreceptor 
[35S]methionine  labeled glycoproteins might be isolated and 
co-migrate with the receptor bands,  these values could be 
minimum estimates. Consistent with these data is the obser- 
vation  that  the  intensity  of  autophosphorylation  of  the 
170,000-D glycoprotein band in differentiated cells (Fig. 9, 
lane  e)  showed a  >90%  decrease compared with  control 
(Fig. 9, lane d), an observation comparable to that made pre- 
viously with intact membranes (Fig. 6;  Table III). 
Discussion 
In this study we have confirmed our earlier reports indicating 
that PC12  cells have functional EGF receptors and shown 
that they express tyrosine kinase activity, a property of these 
receptors in other cell lines or tissues studied (Hunter and 
Cooper, 1985). The data presented confirm and further char- 
acterize the long-term decrease in EGF-binding capacity of 
pheochromocytoma cells induced to differentiate by NGF 
(Huff et al.,  1981). This decrease in EGF-binding capacity, 
originally observed by t25I-EGF binding, is accompanied by 
a decrease in 170,000- and 150,000-D  EGF-receptor species 
visualized by cross-linking experiments, a decrease in EGF- 
stimulated  receptor autophosphorylation  and  EGF-stimu- 
lated tyrosine kinase activity measured with a  src-related 
peptide as substrate, and a possible decrease in the biosyn- 
thesis of the receptor itself as evidenced by a lowered incor- 
poration of [35S]methionine  into a  170,000-D  glycoprotein 
band. 
The present findings are complemented by the data that 
show that the decline in the apparent EGF-binding capacity 
of the differentiated PCI2 cells is not due to changes in EGF 
receptor-binding affinity.  Such a change in receptor affinity 
might  have  been  expected  because  the  physicochemical 
properties of the plasma  membrane of PCI2  cells change 
during differentiation (Guroff, 1985) and also because recep- 
tor affinity was  found to change during  differentiation of 
mouse neuroblastoma cells (Mummery et al., 1983). In both 
control and NGF-differentiated PCI2 cells,  EGF receptors 
were  found to  respond  similarly  to  conditions  that  could 
affect their affinity, pH-induced conformational changes, and 
depolarization. Furthermore, no significant differences in in- 
ternalization, cellular processing of bound EGE or homo- 
down regulation of the receptor were detected when control 
and differentiated cells were compared. 
Indeed, the decrease in EGF-binding capacity of the NGF- 
differentiated PC12 cells appears to involve a reduction in the 
Lazarovici  et al. Regulation of the EGF Receptor by NGF  1619 number of  cell surface (plasma membrane) receptors, caused 
by  a  decreased  receptor  biosynthesis.  Thus,  the  NGF- 
induced loss of EGF receptors from PC12 cells fulfills the 
criteria of a phenomenon of heterologous down regulation 
(Sibley  and  Lefkowitz,  1985). Although  the  short  term 
mechanistic steps responsible for this process need to be elu- 
cidated, it is tempting to consider four alternate hypothetical 
possibilities: (a) in the process of NGF-induced differentia- 
tion an EGF-like material or some transforming factor is 
released  to  the medium thus  affecting EGF  receptor oc- 
cupancy that in the long run leads to decreased receptor bio- 
synthesis; (b) PC12 cells release some glycoproteins into the 
medium in the process of differentiation (Yavin et al., 1986) 
that might include EGF receptors, a process shown to occur 
spontaneously with A431 carcinoma cells (Das et al., 1984); 
(c) the activation of protein kinase C that was shown recently 
to occur in PC12 cells in response to NGF (Hama et al., 
1986) leads to the phosphorylation of EGF receptors, thus 
affecting their binding and tyrosine kinase properties as sug- 
gested with other cells (Cochet and Hunter, 1984; Fearn and 
King, 1985), this phosphorylation then serving as a signal for 
receptor down regulation (Sahyoun et al.,  1985) and/or the 
regulation of receptor biosynthesis (Clark et al., 1985); (d) 
NGF-induced phosphorylation of a  nuclear protein alters 
EGF receptor synthesis. 
The time course of the decrease in EGF receptors in PCI2, 
a 12-24-h lag followed by a gradual loss of receptors for sev- 
eral days, would appear to be the result of some long-term al- 
tered rates of receptor synthesis. Studies considering both 
transcriptional and posttranscriptional.processes are- under- 
way in an effort to understandthe mechanism by which NGF 
induces the heterodown regulation of EGF receptors during 
PC12 cell differentiation. 
The data in this report and in a previous study (Huff  et al., 
1981) support a correlation between the loss of EGF recep- 
tors and the commitment to NGF-induced differentiation of 
the PC12 cells, consistent with the earlier observations that 
NGF inhibits cell division (Greene and Tischler, 1976). One 
interpretation of these data is that the NGF-induced commit- 
ment of proliferating PC12 cells to mature into sympathetic 
neuron-like cells is correlated temporally with the decrease 
in EGF receptor levels  induced by long-term, progressive 
heterologous down-regulation. Such differentiation-related 
changes in EGF-binding capacity are not unique to PCL2 
cells;  similar phenomena were reported in differentiating 
primary cultures of mouse myoblasts (Lim and Hauschka, 
1984)  and during  spontaneous transformation of Chinese 
hamster  embryo  fibroblasts  in  culture  (Wakshull  et  al., 
1985).  In  contrast,  exposure  of teratocarcinoma cells  to 
retinoic acid results in the formation of cells with endoder- 
mal properties and an increase in EGF-binding capacity and 
responsiveness (Adamson and Hogan, 1984). 
Since EGF is only a mild mitogen for PC12 cells (Huff et 
al.,  1981) and myoblasts do not proliferate at all (Lim and 
Hauschka,  1984), the functional implications of changing 
levels of EGF receptors in these systems remain to be estab- 
lished. However,  it is well known that besides its mitogenic 
action, EGF stimulates general metabolic (Hollenberg and 
Cuatrecasas,  1975; Huff et  al.,  1981) and  developmental 
(Johnson et al., 1980) responses. Thus, alternatively, the het- 
ero-down-regulation of EGF receptors  in  the  process  of 
NGF-induced differentiation may represent  a  coordinated 
change in the potential of the differentiated PC12 cell to inter- 
act with the hormonal environment. The reciprocal changes 
in the levels of ¢t- and 13-adrenergic receptors during hepato- 
cyte (Schwarz et al.,  1985) and muscle (Schoenberg et al., 
1978) differentiation are consistent with this suggestion. A 
prime possibility to be considered is that the hetero-down- 
regulation of EGF receptors in PCI2 cells is a reflection of 
a general decrease in the availability of mitogen receptors on 
the surface of the cells during differentiation, thus restricting 
the ability of the differentiated neuron to proliferate. If this 
possibility is correct then it might lead to the suggestion that 
an identical hetero-down-regulatory mechanism exists for 
fibroblast growth factor receptors recently suggested to exist 
on PCI2 cells (Togari et al., 1985). It is tempting to speculate 
that during in vivo adrenal medulla development, temporal, 
and spatial differences in the concentrations of mitogens and 
their receptors on chromaftin cells could be important factors 
in determining the maturation of this organ. 
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